Geulah Livshits
Stock Analyst at Chardan Capital
(4.41)
# 1,231
Out of 4,974 analysts
644
Total ratings
38.1%
Success rate
10.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGX Metagenomi Therapeutics | Maintained: Buy | $7 → $5 | $1.16 | +331.03% | 8 | Jul 7, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $152.95 | +56.91% | 12 | May 20, 2026 | |
| IMTX Immatics | Reiterated: Buy | $25 | $9.50 | +163.16% | 22 | May 19, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $20 | $5.02 | +298.41% | 15 | May 19, 2026 | |
| SNTI Senti Biosciences Holdings | Reiterated: Buy | $13 → $12 | $0.3419 | +3,409.80% | 12 | May 15, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $8 | $0.6993 | +1,044.00% | 21 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $15 | $10.29 | +45.84% | 12 | May 13, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $4.78 | +255.65% | 13 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $3.86 | +184.97% | 39 | May 10, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $26 | $14.94 | +74.03% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.67 | +145.23% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $8.62 | +62.41% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.64 | +112.77% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $4 | $3.08 | +29.87% | 43 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $15.05 | +46.18% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $56.92 | +33.52% | 57 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $369.23 | -12.52% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $12.76 | +135.11% | 51 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $21 | $4.65 | +351.61% | 17 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $150.81 | - | 41 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €1.00 | €0.26 | +289.11% | 8 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7 | $2.11 | n/a | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.10 | n/a | 23 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $14.06 | n/a | 18 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $46.23 | n/a | 6 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.57 | n/a | 11 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.212 | n/a | 12 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.36 | n/a | 3 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $9.84 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.00 | €0.12 | n/a | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $76 | $9.60 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $6 | $3.54 | n/a | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $13.59 | n/a | 10 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $39.49 | n/a | 3 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.0131 | n/a | 5 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $27.33 | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.00001 | n/a | 17 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $48 | $15.98 | n/a | 9 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $0.9618 | n/a | 1 | Jun 4, 2020 |
Metagenomi Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $7 → $5
Current: $1.16
Upside: +331.03%
Palvella Therapeutics
May 20, 2026
Reiterated: Buy
Price Target: $240
Current: $152.95
Upside: +56.91%
Immatics
May 19, 2026
Reiterated: Buy
Price Target: $25
Current: $9.50
Upside: +163.16%
Immuneering
May 19, 2026
Reiterated: Buy
Price Target: $20
Current: $5.02
Upside: +298.41%
Senti Biosciences Holdings
May 15, 2026
Reiterated: Buy
Price Target: $13 → $12
Current: $0.3419
Upside: +3,409.80%
Tenaya Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.6993
Upside: +1,044.00%
Solid Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $10.29
Upside: +45.84%
Lexeo Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.78
Upside: +255.65%
Rocket Pharmaceuticals
May 10, 2026
Reiterated: Buy
Price Target: $11
Current: $3.86
Upside: +184.97%
4D Molecular Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $14.94
Upside: +74.03%
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $3.67
Upside: +145.23%
May 7, 2026
Reiterated: Buy
Price Target: $16 → $14
Current: $8.62
Upside: +62.41%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $5.64
Upside: +112.77%
May 5, 2026
Reiterated: Buy
Price Target: $3.5 → $4
Current: $3.08
Upside: +29.87%
May 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $15.05
Upside: +46.18%
May 4, 2026
Reiterated: Buy
Price Target: $76
Current: $56.92
Upside: +33.52%
May 4, 2026
Reiterated: Buy
Price Target: $323
Current: $369.23
Upside: -12.52%
Apr 27, 2026
Maintained: Buy
Price Target: $27 → $30
Current: $12.76
Upside: +135.11%
Nov 12, 2025
Maintained: Buy
Price Target: $120 → $21
Current: $4.65
Upside: +351.61%
Oct 7, 2025
Rated: Hold
Price Target: n/a
Current: $150.81
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: €1.00
Current: €0.26
Upside: +289.11%
Mar 24, 2025
Maintained: Buy
Price Target: $11 → $7
Current: $2.11
Upside: n/a
Jan 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $5.10
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $41 → $36
Current: $14.06
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $46.23
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $12
Current: $3.57
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.212
Upside: n/a
Jan 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.36
Upside: n/a
Dec 14, 2022
Maintained: Buy
Price Target: $11
Current: $9.84
Upside: n/a
Jul 28, 2022
Reiterated: Buy
Price Target: €15.00
Current: €0.12
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $90 → $76
Current: $9.60
Upside: n/a
Mar 9, 2022
Reiterated: Hold
Price Target: $4 → $6
Current: $3.54
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: $25 → $15
Current: $13.59
Upside: n/a
Jan 5, 2022
Reiterated: Buy
Price Target: $22 → $20
Current: $39.49
Upside: n/a
Dec 17, 2021
Reiterated: Buy
Price Target: $30
Current: $0.0131
Upside: n/a
Aug 20, 2021
Reiterated: Buy
Price Target: $18 → $21
Current: $27.33
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Oct 14, 2020
Maintained: Buy
Price Target: $30 → $48
Current: $15.98
Upside: n/a
Jun 4, 2020
Initiated Coverage: Buy
Price Target: $28
Current: $0.9618
Upside: n/a